trending Market Intelligence /marketintelligence/en/news-insights/trending/8kbhnodan_ddfkher_67rg2 content esgSubNav
In This List

Clementia Pharmaceuticals names board member

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Clementia Pharmaceuticals names board member

Montreal-based Clementia Pharmaceuticals Inc. appointed Shawn Tomasello to its board.

Tomasello was most recently chief commercial officer of Kite Pharma Inc.

Meanwhile, Jean-François Pariseau, who has served on the company's board since 2012, stepped down, effective immediately.

Clementia develops treatments for ultra-rare bone disorders and other diseases with high medical need.